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Abstract
Background: The aim of the study was to obtain stable radioresistant sub-lines from the human cervical cancer
cell line HeLa by prolonged exposure to
252Cf neutron and X-rays. Radioresistance mechanisms were investigated
in the resulting cells using microarray analysis of DNA damage repair genes.
Methods: HeLa cells were treated with fractionated
252Cf neutron and X-rays, with a cumulative dose of 75 Gy
each, over 8 months, yielding the sub-lines HeLaNR and HeLaXR. Radioresistant characteristics were detected by
clone formation assay, ultrastructural observations, cell doubling time, cell cycle distribution, and apoptosis assay.
Gene expression patterns of the radioresistant sub-lines were studied through microarray analysis and verified by
Western blotting and real-time PCR.
Results: The radioresistant sub-lines HeLaNR and HeLaXR were more radioresisitant to
252Cf neutron and X-rays
than parental HeLa cells by detecting their radioresistant characteristics, respectively. Compared to HeLa cells, the
expression of 24 genes was significantly altered by at least 2-fold in HeLaNR cells. Of these, 19 genes were up-
regulated and 5 down-regulated. In HeLaXR cells, 41 genes were significantly altered by at least 2-fold; 38 genes
were up-regulated and 3 down-regulated.
Conclusions: Chronic exposure of cells to ionizing radiation induces adaptive responses that enhance tolerance of
ionizing radiation and allow investigations of cellular radioresistance mechanisms. The insights gained into the
molecular mechanisms activated by these “radioresistance” genes will lead to new therapeutic targets for cervical
cancer.
Background
Cervical cancer is a worldwide disease, with a high inci-
dence and mortality [1] especially in developing coun-
tries. Approximately 500,000 cases of cervical cancer are
diagnosed annually, with mortality around 40% [2].
Radiotherapy is particularly effective for patients with
cervical cancers at an advanced stage or that cannot be
cured surgically. Low LET radiation (e.g., gamma rays,
X-rays) is generally used to treat cervical cancers, but its
ability to cure local disease decreases with increasing
tumor size, because the doses required to treat large
tumors exceed the toxicity limits of normal tissues [3].
High LET radiation such as neutron rays is associated
with a low rate of repair of potentially lethal DNA
damage, allowing better local control of the tumor and
thus less chance of recurrence. Theoretically, high LET
radiation has several advantages over low LET radiation:
(a) more damage to hypoxic cells; (b) decreased repair
of IR-induced damage; and (c) effectiveness at all stages
of the cell cycle [4]. The 5-year overall survival rate of
cervical cancer patients who received
252Cf neutron ray
radiotherapy was reported to be 76.8% at stage II and
70.9% at stage III [5]. Another study showed that the
10-year survival rate was better in cervical cancer
patients treated with
252C fn e u t r o nr a y st h a ni nt h o s e
treated with gamma radiation (69.1% vs. 50.9%,
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any medium, provided the original work is properly cited.respectively) [6]. However, despite the improved efficacy
of
252Cf neutron rays in the therapy of cervical cancer,
tumors recurrence has been reported.
A substantial body of evidence has implicated DNA as
the primary target in lethal ionizing radiation (IR) [7].
In many human tumor lines, radiosensitivity correlated
with DNA damage induction and repair [8-10]. The
activity of the DNA damage repair pathway is one of
the most important factors leading to radioresistance in
tumors, including cervical cancer. This pathway as well
as others contributing to radioresistance in cervical can-
cer can be studied by cDNA microarray analyses of
gene expression. Thus, in the present work, long-term
252Cf neutron ray and X-ray irradiation of HeLa cells
was used to generate two radioresistant cell sub-lines,
HeLaNR and HeLaXR, which provided a model system
for studying the radioresistance mechanisms of cervical
cancer cells. Insights into the mechanisms of resistance
will contribute to improvements in cancer treatment.
Methods
Cell lines
The HeLa cell line was obtained from the American Type
Culture Collection and cultured in DMEM-high glucose
medium (GIBCO) supplemented with 10% newborn calf
serum (Biochrom AG), penicillin (100 U/ml), and strep-
tomycin (100 μg/ml) (Sigma). Cells were incubated in 5%
CO2 at 37°C and passaged 2-3 times weekly.
252Cf neu-
tron ray (HeLaNR) and X-ray (HeLaXR) resistant sub-
lines were generated by continuous sublethal irradiation
for 8 months with
252Cf neutron and X-rays, respectively,
with a total dose of 75 Gy each. The parental cell line
(HeLa) and the radioresistant sub-lines (HeLaNR and
HeLaXR) were maintained under the same conditions.
To control for acute effects of IR, the radioresistant sub-
lines were cultured for over 2 months after the last irra-
diation before being used in the analyses.
Irradiation
For X-ray treatment, cells were cultured in 25-cm
2
flasks until they reached 75% confluence and then irra-
diated at 200 cGy/min, at room temperature, with a Pre-
cise linear accelerator (Elekta) operating at 8 MV. For
252Cf neutron ray treatment, trypsinized cells were har-
vested in a tube and then irradiated with a neutron
emission rate of 2.3 × 10
6/s/μg, a g emission rate of 1.3
×1 0
7/s/μg, and a dose rate in air of 23.4 mSv/h￿mg at 1
cm from the source.
Colony formation assay
HeLa, HeLaNR, and HeLaXR cells were treated with 0,
2, 4, 6, 8, and 10 Gy of
252Cf neutron or X-ray radiation.
After 2 weeks, clones were fixed with methanol and
stained with a 2% Giemsa solution (Merck) for 10 min.
Stained clones that had more than 50 cells were counted
and cloning efficiency calculated as: cloning efficiency =
(clone number/total cell number)*100%. The cell survi-
val fraction (SF) was determined. A cell survival curve
was drafted using Microsoft Excel 2003 software and
the single-hit multi-target model SF = 1- (1-e
-D/D0)
N,
where SF is the survival fraction; D, the radiation dose;
D0, the mean death dose; and N, the extrapolated num-
ber. Dq, the standard threshold dose, was determined
from logN = Dq/D0; and SF2, the fraction surviving at 2
Gy, from the cell survival curve.
Transmission electron microscopy (TEM)
HeLa, HeLaNR, and HeLaXR cells were harvested in
exponential growth phase and centrifuged at 1500 rpm
for 10 min at 4°C. Cell pellets were fixed in a 2.5% glu-
taraldehyde solution. Fixed cells were washed twice with
PBS, dehydrated three times sequentially in a graded
series of acetone solutions, and then incubated over-
night in a 1:1 volume ratio of 100% alcohol and embed-
ding resin. Resin-embedded cells were placed in
capsules and then transferred to a Pelco UV-2 Cryo
Chamber, where they were polymerized with UV irra-
diation at 4°C for 48 h. Ultrathin sections were prepared
and then stained with uranyl acetate and lead citrate.
Cellular uptake of nanoparticles was evaluated by TEM
(TECNAI10, Philips).
Cell doubling time
HeLa, HeLaNR, and HeLaXR cells were trypsinized in
exponential growth phase. Equal numbers of cells
(about 1 × 10
4) were plated in 6-well culture plates (day
0) and cultured in 5% CO2 at 37°C. Viable cells were
determined by the trypan blue exclusion test and
counted in triplicate on days 1, 2, 3, 4, 5, and 6.
Cell cycle analysis
HeLa, HeLaNR, and HeLaXR cells were treated with 0,
4, and 16 Gy of
252Cf neutron ray and X-ray radiation.
At 24 h post-irradiation, the cells were harvested, fixed
with 70% ethanol, and then stored at 4°C. Cell cycle
analysis was carried out by flow cytometry (FACSCali-
bur, Becton Dickinson) at 488 nm.
Apoptosis analysis
HeLa, HeLaNR and HeLaXR cells were treated with 0, 4
and 16 Gy of
252Cf neutron ray and X-ray radiation. At
48 h post-irradiation, the cells were harvested and then
stained with annexin V-FITC and PI (Invitrogen). Cell
apoptosis analysis was carried out by flow cytometry.
RNA preparation and microarray analysis
Total RNA was isolated from HeLa, HeLaNR, and
HeLaXR cells with TRIzol® (Invitrogen) according to the
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ray® Human DNA Damage Signaling Pathway Microar-
ray) was used following the manufacturer’sp r o t o c o lt o
compare the gene expression profiles of the three cell
lines, and the results interpreted with the GEArray
Expression Analysis Suite. SuperArray contains 113
functionally well-characterized genes associated with the
ATR/ATM signaling network, including transcriptional
targets of DNA damage response (cell cycle arrest,
apoptosis, and DNA repair). Controls consist of four
normalizable genes (glyceraldehyde-3-phosphate dehy-
drogenase, beta-2-microglobulin, heat-shock protein 90-
a,a n db-actin) and a blank. The experiment was per-
formed more than three times using different RNA pre-
parations. The microarray data had been deposited in
GEO database of NCBI. The Series number was
GSE19526 http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE19526 and the Platform number was
GPL9811 http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GPL9811.
Western blotting
Total protein extracts were prepared from HeLa,
HeLaNR, and HeLaXR cells. The proteins (20 μg/sam-
ple) were resolved by electrophoresis on 12% SDS-polya-
crylamide gels, transferred to polyvinylidene difluoride
membranes, and blocked in TBST [50 mM Tris-HCl,
pH 7.5, 150 mM NaCl and 0.1% (v/v) Tween 20] con-
t a i n i n g5 %( w / v )n o n f a td r ym i l k .T h em e m b r a n ew a s
incubated with a 1:2000 dilution of GADD45a (mouse
monoclonal antibody, Abnova) and a 1:1000 dilution of
BTG2 (goat polyclonal IgG, Santa Cruz) primary anti-
body overnight at 4°C, washed three times in TBST, and
then incubated with a 1:2000 dilution of horseradish-
peroxidase-labeled secondary antibody (Pierce) for 1
hour at 37°C. The membrane was then reacted with
chemiluminescent reagents (Pierce) and exposed onto
film (Kodak). Bands intensities were analyzed using the
Gel Doc 2000 apparatus and software (Quantity One,
Bio-Rad). Protein loading was normalized with b-actin
(Sigma).
Real-time PCR
Total RNA was isolated from HeLa, HeLaNR, and
HeLaXR cells. Reverse transcription was performed
with AMV reverse transcriptase (TaKaRa) and oli-
godT18 primers (TaKaRa). Real-time PCR was carried
out using SYBR Green I (Molecular Probes) and the
iQCycler thermocycler (Bio-Rad). Relative expression
of the GADD45a and BTG2 genes was measured by
real-time quantitative RT-PCR using b-actin as internal
control for possible contamination of genomic
DNA and for normalization of variation in the
amounts of PCR product loaded. Primer sequences
were: 5’-AGTCAGCGCACGATCACTGTC-3’ (forward)
and 5’-GACGCGCAGGATGTTGATGTC-3’ (reverse)
for GADD45a, which generated a 183-bp fragment; 5’-
ACATGAGCCACGGGAAGGGAAC-3’ (forward) and
5’-ATGCGAATGCAGCGGTAGCC-3’ (reverse) for
BTG2, which generated a 211-bp fragment. Real-time
PCR was carried out as follows: initial denaturation for
5 min at 94°C and 42 PCR cycles consisting of 15 s at
94°C, 15 s at 58°C, and 18 s at 72°C. Standards and
cDNA samples were amplified in triplicate in the same
reaction plate in at least three independent
experiments.
Statistical analysis
Quantitative data were obtained from three independent
experiments and expressed as mean ± SD. Statistical dif-
ference between two groups was determined using Stu-
dent’s t test. P values were-two sided; P <0 . 0 5w a s
considered as statistically significant.
Results
Radiosensitivity
Radiation-survival curves, generated according to the
above-described methods, were derived from colony for-
mation assays of the three cell lines after different doses
of
252Cf neutron and X-rays (Figure 1). These curves
were then used to determine D0,D q,a n dS F 2( T a b l e1 ) .
Under equal doses of
252Cf neutron ray and X-ray irra-
diation, the D0,D q,a n dS F 2v a l u e so ft h eH e L a N Ra n d
HeLaXR cells were higher than those of the HeLa cells,
indicating that the sub-lines were more radioresistant
than the parent cells.
Figure 1 Survival fraction curves of HeLa, HeLaNR and HeLaXR
cells. The radiation survival fraction curve derived from colony
formation assays of HeLa, HeLaNR, and HeLaXR cells after different
doses of
252Cf neutron rays and X-rays. HeLaNR and HeLaXR cells
are more radioresistant to IR than parental cells.
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The ultrastructure of HeLa, HeLaNR, and HeLaXR cells
was examined by TEM (Figure 2). In HeLa cells, micro-
villi were present on the surface and the cytoplasm con-
tained abundant mitochondria and ribosomes. In the
radioresistant sub-lines, swelling of mitochondria,
vacuolization, dilatation of the endoplasmic reticulum,
and myelin figures were observed. Thus, in the HeLaNR
and HeLaXR sub-lines, the ultrastructural changes
induced by long-term irradiation persisted even > 2
months after the last radiation treatment.
Cell proliferation
Cell doubling time, td, was estimated by the following
formula:
tt t X X d =− ln *( ) / ln( / ) 2 21 2 1
where X1 and X2 are the number of cultured cells at
the current (t2)a n dp r e v i o u s( t1) measurements. As
shown in Figure 3, the cell doubling times of the
HeLaNR and HeLaXR cells (33.12 ± 3.67 h, and 36.94 ±
3.16 h, respectively) were longer than those of the par-
ent HeLa cells (28.62 ± 2.77 h).
Cell cycle distribution
The cell cycle distribution of HeLa, HeLaNR, and HeLaXR
cells 24 h after
252Cf neutron ray and X-ray irradiation
was determined by flow cytometry (Figure 4). In HeLa
cells, exposure to a radiation dose of 4 Gy significantly
increased the proportion of cells in G2 and decreased the
proportion of cells in G1. The proportion of G2-arrested
HeLa cells was even greater following 16-Gy irradiation.
In the HeLaNR and HeLaXR sub-lines, however, the pro-
portion of cells in G2 did not increase after irradiation
with 4 Gy. At 16 Gy, cells of both sub-lines became
arrested in G2 but the proportion was much lower than in
HeLa cells. Thus, cells of the radioresistant sub-lines prob-
ably arrested in the G1 phase of the cell cycle.
Cell apoptosis
The level of apoptosis was analyzed by flow cytometry
48 h after 0, 4, and 16 Gy
252Cf neutron ray and X-ray
irradiation (Figure 5). At 0 Gy, the apoptosis rate was
0.93-2.71% for all three cell lines. At 4 and 16 Gy, the
apoptosis rate of HeLa cells was much higher than that
of the radioresisitant sub-lines (4 Gy: 9.32 vs 3.84, 7.94
vs 5.43; 16 Gy: 22.47 vs 7.28, 20.03 vs 11.1, p < 0.05).
Thus, the sub-lines HeLaXR and HeLaNR were more
radioresistant than the parental HeLa cell line.
Gene expression
Using stringent criteria for array analysis (≥2-fold change
in expression), we identified 113 genes related to DNA
damage signaling pathways that were differentially
expressed in the parental HeLa cells compared to radio-
resistant HeLaXR and HeLaNR cells (Table 2). Of the 24
genes significantly altered by at least 2-fold in HeLaNR
cells, 19 were up-regulated and 5 down-regulated. Like-
wise, of the 41 genes significantly altered by at least
2-fold in HeLaXR cells, 38 were up-regulated and 3
down-regulated. For the two radioresistant sub-lines, the
similar overall trend in gene-expression changes indi-
cated that long-term exposure to
252Cf neutron and X-
rays had resulted in a similar induction of genes involved
Figure 2 Ultrastructural features of HeLa, HeLaNR, and HeLaXR
cells examined by TEM (×3,700). Microvilli are present on the
HeLa cell surface and the cytoplasm contains abundant
mitochondria and ribosome. In the radioresistant sub-lines,
mitochondrial swelling, vacuolization, dilatation of the endoplasmic
reticulum, and myelin figures are seen.
Figure 3 Cell growth curves of HeLa, HeLaNR and HeLaXR cells.
The cell doubling time of HeLaNR and HeLaXR cells is 33.12 ± 3.67 h
and 36.94 ± 3.16 h, respectively, is longer than that of the parent
HeLa cells (28.62 ± 2.77 h).
Table 1 D0,D q, and SF2 values in HeLa, HeLaNR, and
HeLaXR cells
Group D0 (Gy) Dq (Gy) SF2
HeLa-N 1.45 0.59 0.52
HeLaNR-N 1.84 0.67 0.61
HeLa-X 1.58 0.61 0.55
HeLaXR-X 1.88 0.7 0.63
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homologous recombination, nonhomologous end-joining,
mismatch repair, and cell cycle arrest functions were
more highly expressed in cells resistant to X-rays than in
cells resistant to
252Cf neutron rays.
Western blotting and real-time PCR
Changes in gene expression detected in the microarrays
were validated by Western blotting and real-time PCR.
Based on the results shown in Figure 6, two genes,
BTG2 and GADD45a, were chosen for further analysis
and validation of the microarray data by Western blot-
ting and real-time PCR. As shown by Western blotting,
BTG2 protein expression was up-regulated in the resis-
tant sub-lines, especially in HeLaNR cells, while the
expression of GADD45a protein was down-regulated in
both resistant sub-lines. PCR analysis showed that
BTG2 and GADD45a mRNA expression paralleled that
of the respective proteins.
Discussion
Chronic exposure of cells to IR induced an adaptive
response that resulted in enhanced tolerance to the sub-
sequent cytotoxicity of IR [11-13]. In this study, HeLa
cells were irradiated with fractionated
252Cf neutron and
X-rays, yielding two radioresistant cell sub-lines. The
mechanisms of this increased cellular radioresistance
were investigated by comparing changes in the gene
expression profiles of the parent HeLa cells with those
of the HeLaNR and HeLaXR sub-lines.
Post-irradiation survival of the radioresistant sub-lines
was significantly higher than that of the parental cells,
with increased D0 and Dq. This resistant phenotype
appears to be stable because it did not change after con-
tinuous culture of the sub-lines for > 2 months in the
absence of further irradiation. Similar findings were
reported in the radioresistant human fibrosarcoma cell
line HT1080R, obtained by long-term exposure to
X-rays [14]. In Escherichia coli, radioresistant mutant
bacterial strains were produced by daily X-ray irradia-
tion [15]. Radiation resistance after long-term fractio-
nated radiation has also been reported for breast [16],
pancreatic [17], esophageal [18], and nasopharyngeal
[19] cancer cells.
Tumor cells are heterogeneous with respect to their
radioresponsiveness. The radioresistant phenotype is
ascribed to several factors, including alterations in cell
cycle checkpoints, slowed growth, and decreased apop-
tosis [20]. Here, the ultrastructure, proliferation, cell
cycle distribution, and apoptosis rate of the radioresis-
tant sub-lines were studied. As shown by TEM, HeLaNR
and HeLaXR cells were ultrastructurally altered after
long-term exposure to IR, even after > 2 months of cul-
ture after the last radiation dose. The cell doubling
times of these sub-lines were longer than that of HeLa
cells, consistent with the results of Russell et al. [11].
The cell cycle distribution pattern is strongly dis-
turbed by irradiation; in turn, radiosensitivity depends
on cell cycle position and cell cycle progression [21]. In
a previous study, radiosensitive AT cells were shown to
lack G1 arrest, accumulating instead at G2, while the
G2 phase of radioresistant REC-derived cells was signifi-
cantly prolonged [22]. We found that HeLaNR, HeLaXR,
and HeLa cells differed in their cell cycle distribution,
with HeLaNR and HeLaXR sub-lines most likely
arrested in G1. This difference between the parent and
the two sub-lines may reflect their different radiosensi-
tivities. Likewise, IR-induced apoptosis was found to be
better tolerated by the radioresistant HeLaNR and
HeLaXR cells than by the parental HeLa cells. Previous
studies provided evidence of the important role played
by apoptosis in radiation-induced cell death and as a
determinant of radiosensitivity [23,24].
Figure 4 Cell cycle distribution in the parent HeLa cells and
the two radioresistant sub-lines 24 h after irradiation. Exposure
of HeLa cells to a radiation dose of 4 Gy significantly increased the
proportion of cells in the G2 phase of the cell cycle and decreased
the proportion of cells in G1. The degree of G2 arrest was more
apparent after irradiation with 16 Gy. The cell cycle distribution
pattern of the radioresistant sub-lines also changed but without an
increase in G2 cells after irradiation with 4 Gy. Increasing the
irradiation doses to 16 Gy induced G2 arrest but the proportion of
arrested cells was much lower than in the HeLa cell population.
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to detect the biological response of thousands of genes
to external stimuli, including IR [25]. Gene expression
profiling by DNA microarray has been applied to classify
disease stages and predict treatment response to radio-
therapy in cervical cancer [26-31]. In these previous stu-
dies, sets of genes associated with pathways such as
apoptosis (e.g., bax, bcl-2), DNA damage repair (e.g.,
K u 8 0 ,G A D D 4 5 ,X R C C 5 ) ,c e l la d h e s i o n( e . g . ,I C A M - 3 ) ,
angiogenesis (e.g., HIF-1a), and tumor cell invasion (e.g.,
CTSL, CTSB) were identified.
Here, microarray analysis was used to identify the
gene expression patterns of two radioresistant sub-lines
derived from HeLa cells. Although many stress-respon-
sive genes are inducible by IR [32], we found that the
expression of only a small fraction of the radiation-indu-
cible genes, such as those involved in cell cycle
checkpoints, apoptosis, and DNA repair [33], was
altered in our radioresistant sub-lines. For the two
radioresistant sub-lines, the similar overall trend in
gene-expression changes indicated that long-term expo-
sure to
252Cf neutron and X-rays had resulted in a simi-
lar induction of genes involved in DNA damage
signaling pathways. The number of genes that are
involved in homologous recombination and nonhomolo-
gous end-joining, processes that result in altered gene
expression, was higher in HeLaXR cells (8 and 3, respec-
tively) than in HeLaNR cells (2 and 1, respectively).
Furthermore, the number of cell cycle arrest and mis-
match repair genes expressed was higher in HeLaXR
cells (7 and 3, respectively) than in HeLaNR cells (3
and 1, respectively) whereas the number of base exci-
sion repair genes expressed in the two sub-lines was
almost the same (4 in HeLaXR cells and 5 in HeLaNR
Figure 5 Apoptosis assay in three cells after irradiation at 48 h. Apoptosis assay of HeLa cells and the radioresistant two sub-lines
48 h after irradiation. At 0 Gy, the apoptosis rate was 0.93-2.71%for all three cell lines. The difference in the apoptosis rate between HeLa cells
vs. HeLaXR and HeLaNR cells significantly increased with higher radiation doses (4 Gy: 9.32 vs 3.84, 7.94 vs 5.43; 16 Gy: 22.47 vs 7.28, 20.03 vs 11.1,
p < 0.05).
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GeneBank Symbol Gene Function Regulation Mode
HeLaNR* HeLaXR*
NM_000051 ATM Other genes involved in DNA repair up
NM_006763 BTG2 Other genes involved in DNA repair up
NM_001279 CIDEA Apoptosis genes up up
NM_014430 CIDEB Apoptosis genes up up
NM_000082 CKN1 Nucleotide excision repair up
NM_001923 DDB1 Nucleotide excision repair up up
NM_007068 DMC1 Nucleotide excision repair up
NM_005236 ERCC4 Nucleotide excision repair up
NM_006705 GADD45G Apoptosis genes up
NM_001515 GTF2H2 Nucleotide excision repair up
NM_016426 GTSE1 Cell cycle arrest up
NM_004507 HUS1 Cell cycle arrest up
NM_054111 IHPK3 Apoptosis genes up
NM_001567 INPPL1 Other genes involved in DNA repair up up
NM_033276 KUB3 Nonhomologous end-joining up up
NM_000234 LIG1 Nucleotide excision repair up
NM_002758 MAP2K6 Cell cycle arrest up
NM_002969 MAPK12 Cell cycle arrest up up
NM_005590 MRE11A Homologous recombination up
NM_018177 N4BP2 Other genes involved in DNA repair up
NM_002528 NTHL1 Base excision repair up up
NM_020418 PCBP4 Apoptosis genes up
D38500 PMS2L4 Mismatch repair up
NM_005395 PMS2L9 Mismatch repair up
NM_007254 PNKP Base excision repair up up
NM_014330 PPP1R15A Apoptosis genes up
NM_006904 PRKDC Nonhomologous end-joining up
NM_002873 RAD17 Cell cycle arrest up
NM_006265 RAD21 Apoptosis genes up
NM_005053 RAD23A Nucleotide excision repair up
NM_002875 RAD51 Homologous recombination up
NM_133509 RAD51L1 Homologous recombination up
NM_002878 RAD51L3 Homologous recombination up
NM_002879 RAD52 Homologous recombination up up
NM_003579 RAD54L Homologous recombination up
NM_004584 RAD9A Cell cycle arrest up
NM_016316 REV1L Other genes involved in DNA repair up
NM_000546 TP53 Apoptosis genes up
NM_016381 TREX1 Mismatch repair up
NM_007205 TREX2 Other genes involved in DNA repair up
NM_003362 UNG Base excision repair up up
NM_021147 UNG2 Base excision repair up up
NM_005431 XRCC2 Homologous recombination up
NM_005432 XRCC3 Homologous recombination up up
NM_003401 XRCC4 Nonhomologous end-joining up
NM_001239 CCNH Nucleotide excision repair down
NM_004083 DDIT3 Cell cycle arrest down down
NM_001924 GADD45A Apoptosis genes down down
NM_002311 LIG3 Base excision repair down
NM_000534 PMS1 Mismatch repair down
NM_002873 RAD17 Cell cycle arrest down
* compared with HeLa cells
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Page 7 of 9cells). Hence, our results indicated that the expression
of genes encoding homologous recombination, nonho-
mologous end-joining, mismatch repair, and cell cycle
arrest functions was more closely related to X-ray
radioresistance than to
252Cf neutron ray
radioresistance.
BTG2 and GADD45a mRNA and protein expression
levels were determined by real-time PCR and Western
blot and the results confirmed the microarray data.
BTG2 is an antiproliferative gene and one of the early
growth response genes [34]. In a previous study, we
investigated the expression of BTG2 and its role in
hepatic cancer [35]. BTG2 overexpression inhibits G1-S
progression through transcriptional regulation of cyclin
D1 in the presence of pRB [36]. In NIH3T3 cells, forced
expression of BTG2 provoked a marked inhibition of
cell proliferation [34]. BTG2 was also identified as a dif-
ferentiation and anti-apoptotic factor in neurogenesis
[37]. In the present study, BTG2 mRNA and protein
were found to be overexpressed in the two radioresistant
sub-lines, suggesting that BTG2 plays an important role
in resistance to IR-induced apoptosis and G1 arrest.
GADD45a is a downstream target of p53 and a mem-
ber of a group of genes induced by DNA damaging
agents and growth arrest signals. KLOPP et al [38]
examined 12 cervical cancer patients with microarray
a n df i n dt h a tG A D D 4 5 a is upregulated by radiation in
NED (no evidence of disease) patients (1.13) and down-
regulated (0.96) in recurrent-disease patients (p = 0.36).
Moreover, we find that the expression of GADD45a is
downregulated in radioresitant sublines HeLaNR and
HeLaXR. GADD45a is thought to be involved in cell
cycle control at the G2-M checkpoint [39] and in the
induction of cell death [40,41] following DNA damage.
It may interact with MEKK4/MTK1 [40] and activates
the JNK/p38 [41] signaling pathway, which induces
apoptosis. Thus, low-level expression of GADD45a may
in part explain the radioresistance of HeLaNR and
HeLaXR cells to IR-induced apoptosis.
Conclusions
In the present study, radioresistance mechanisms in cells
chronically exposed to IR were investigated using DNA
microarray analysis. Comprehensive expression profiles
of genes involved in DNA damage signaling pathway
were generated in HeLa and two radioresistant sub-lines
in order to identify those genes whose expression corre-
lated with radioresistance. Further investigations of
these and other “radioresistance” genes will provide new
insights in our understanding of the molecular mechan-
isms of radioresistance, potentially leading to new thera-
peutic targets for cervical cancer.
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